Orexo AB (FRA:C5G)
€ 0.885 0.004 (0.45%) Market Cap: 31.52 Mil Enterprise Value: 73.01 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Q4 2020 Orexo AB Earnings Call Transcript

Jan 28, 2021 / 01:00PM GMT
Release Date Price: €4.92 (-3.44%)
Operator

Hello, and welcome to Orexo Interim Report Q4 2020. (Operator Instructions) Today, I am pleased to present Nikolaj Sørensen, CEO; and Joseph DeFeo, CFO. Please begin your meeting.

Nikolaj SÃ;rensen;publ;President;CEO
Orexo AB

¸ - ()-&

Thank you very much, and good afternoon to those of you in Sweden. Good morning to those of you who are out in the U.S. So this is our full year report and Q4 record for 2020, a year, which I think in many ways, we have made a lot of transformative actions and made a lot of progress in Orexo. But it's clearly also a year where the COVID-19 have had a little harder grip on the society than we had expected when we started in March, and also had some impact on our business both in terms of our ZUBSOLV business, but also digital therapies. And the unfortunate effect of COVID-19 is that the disease areas that we are working in, opioid dependence and mental health, is something that will be very negatively impacted. And we already now see a dramatic increase in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot